4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Kirn David sold 58,333 4d Molecular Therapeutics, Inc. shares (Form 4)
Traded Jul 9 to Jul 10, 2026 · Filed Jul 14, 2026
From Jul 9 to Jul 10, 2026, Kirn David (Director, See Remarks) sold 58,333 4d Molecular Therapeutics, Inc. shares at an average US$12.64 for US$738K under a trading plan, leaving 884,152 shares. Filed Jul 14, 2026 (Form 4).
- Sold
- 58,333 shares
- Price
- US$12.64 average (US$12.01 to US$12.87)
- Value
- US$738K
- Holding after
- 884,152 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | Sale | 42,608 | US$12.87 | 899,877 | Direct |
| Jul 10, 2026 | Common Stock | Sale | 15,283 | US$12.01 | 884,594 | Direct |
| Jul 10, 2026 | Common Stock | Sale | 442 | US$12.84 | 884,152 | Direct |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Kirn David
- 4d Molecular Therapeutics, Inc. shareholders
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Kirn David · Aug 21, 2026
- Form 4 · Kirn David · Aug 5, 2026
- Form 4 · Kirn David · Aug 4, 2026
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Bizily Scott · Sep 3, 2026
- Form 4 · Bizily Scott · Aug 17, 2026
- Form 4 · Bizily Scott · Jul 2, 2026